Pages that link to "Q50883499"
Jump to navigation
Jump to search
The following pages link to Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-up (Q50883499):
Displaying 30 items.
- Risk factors for vascular dementia: hypotension as a key point (Q24648731) (← links)
- Neurocardiovascular Instability and Cognition (Q26738343) (← links)
- Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden (Q28074728) (← links)
- Hypertension, cognitive decline, and dementia: an epidemiological perspective (Q33284785) (← links)
- Alzheimer's disease and vascular dementia. Some points of confluence (Q33922757) (← links)
- Effects of hypertension and its treatment on mental function (Q34028235) (← links)
- Examining the influence of gender, education, social class and birth cohort on MMSE tracking over time: a population-based prospective cohort study (Q34378577) (← links)
- Hypertension and cognitive function: Pathophysiologic effects of hypertension on the brain (Q35118333) (← links)
- Relation of Blood Pressure to Cognitive Impairment and Dementia (Q35917114) (← links)
- The age-dependent relation of blood pressure to cognitive function and dementia (Q36201875) (← links)
- Is mid-life social participation associated with cognitive function at age 50? Results from the British National Child Development Study (NCDS) (Q36210667) (← links)
- Models and mechanisms of vascular dementia (Q36244982) (← links)
- Blood pressure treatment and cognition in the elderly (Q36812775) (← links)
- Vascular risk factors, cognitive decline, and dementia (Q36812802) (← links)
- Neuroimaging of cognitive impairments in vascular disease (Q37510086) (← links)
- B-Vitamin Intake and Biomarker Status in Relation to Cognitive Decline in Healthy Older Adults in a 4-Year Follow-Up Study. (Q37628425) (← links)
- Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (Q43290386) (← links)
- Cognitive changes in prevalent and incident cardiovascular disease: a 12-year follow-up in the Maastricht Aging Study (MAAS). (Q47600391) (← links)
- Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition (Q48002156) (← links)
- A unifying hypothesis of Alzheimer's disease. III. Risk factors (Q48458709) (← links)
- Systolic blood pressure decline in very old individuals is explained by deteriorating health: Longitudinal changes from Umeå85+/GERDA. (Q49285382) (← links)
- Asymptomatic spontaneous cerebral emboli and cognitive decline in a cohort of older people: a prospective study. (Q50795229) (← links)
- Age-related effects of blood pressure on everyday cognitive function in community-dwelling women. (Q51850322) (← links)
- The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women. (Q51894479) (← links)
- Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population. (Q51913116) (← links)
- Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age. (Q51940087) (← links)
- [Cerebral complications of hypertension in the elderly] (Q77125683) (← links)
- Hypertension and dementia (Q77323577) (← links)
- [Towards a prevention of dementia?] (Q79805905) (← links)
- Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit (Q93185032) (← links)